NCT06983834 Mindfulness Psychoeducation for Bipolar Disorder Caregivers' Mindfulness, Burden, Quality of Life and Resilience
| NCT ID | NCT06983834 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pamukkale University |
| Condition | Bipolar Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 46 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2025-09-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 46 participants in total. It began in 2025-05-01 with a primary completion date of 2025-09-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study was designed to determine the effect of mindfulness-based psychoeducation applied to primary caregivers of individuals diagnosed with bipolar disorder on their mindfulness, caregiver burden, quality of life, and psychological resilience.
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older, * At least a primary school graduate, * Able to hear, understand spoken language, and communicate, * Has been a primary caregiver for at least 6 months and is participating voluntarily. Exclusion Criteria: * Currently participating in another psychoeducation group, * Diagnosed with any mental disorder.
Contact & Investigator
Gülay TAŞDEMİR, AssocProfDr
STUDY DIRECTOR
https://akbis.pau.edu.tr/personel/226
Frequently Asked Questions
Who can join the NCT06983834 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bipolar Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06983834 currently recruiting?
Yes, NCT06983834 is actively recruiting participants. Contact the research team at korkmazime@gmail.com for enrollment information.
Where is the NCT06983834 trial being conducted?
This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).
Who is sponsoring the NCT06983834 clinical trial?
NCT06983834 is sponsored by Pamukkale University. The principal investigator is Gülay TAŞDEMİR, AssocProfDr at https://akbis.pau.edu.tr/personel/226. The trial plans to enroll 46 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.